News

11Oct

Invivoscribe Controls Portfolio Catalogue 2024

Discover the Invivoscribe control portfolio

Invivoscribe offers an extensive range of General Purpose Reagents (GPRs) and Research Use Only (RUO) controls.

BCR/ABL1, cell line dna, cGMP conditions, control, DNA, FLT3 ITD, flt3 tkd, general purpose reagents, igh-bcl2, invivoscribe, minimal residual disease, MRD, next-generation sequencing assays, NGS, plasmid dna, tissue dna

08Oct

Molecular

Think Biocartis Idylla

WHEN TIME MATTERS. THINK BIOCARTIS IDYLLA*. YOUR BIOMARKER TEST RESULTS WITHIN 3 HOURS.

The Idylla™ solution is a revolutionary, fully automated, real-time PCR based molecular testing system designed to offer results in a minimum amount of time.

AKT1, ALK, biocartis, braf, EGFR, GeneFusion, IDH1-2, idylla, KRAS, METex14, msi, NGS, nras, NTRK, NTRK1, NTRK2, NTRK3, PIK3CA, RET, ROS1

21Mar

Molecular

Advantages of Using LymphoTrack Assays

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.

Invivoscribe LymphoTrack^®products can be used for next-generation sequencing (NGS) determination and minimal residual disease (MRD) tracking of B- and T-cell gene rearrangements in subjects suspected of lymphoproliferations.

Clonality testing, invivoscribe, lymphotrack, NGS

21Mar

Molecular

Devyser LynchFAP NGS

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.

Devyser LynchFAP¹ is the first kit on the market to accurately assess all PMS2 variants!

First commercial kit to include a long-range PCR to unambiguously determine variants in all PMS2 exons.

APC, cancer, CTNNB1, Devyser, EPCAM, FAP, Lynch, LynchFAP, MLH1, molecular, MSH2, MSH6, MUTYH, NGS, PMS2, POLD1, POLE

23Jan

Molecular

Biocartis Idylla™ GeneFusion Panel

Products are for professional/laboratory use only

Within 180 minutes and with less than 2 minutes hands-on time, the fully automated Idylla™ GeneFusion cartridge detects ALK, ROS1 and RET fusions & MET exon 14 skipping in a single cartridge using only 1-3* FFPE tissue sections from patients with NSCLC.

biocartis, EGFR, gene fusion, GeneFusion, idylla, NGS, NSCLC

05Jul

Haematology, Molecular

Advantages of NGS for MRD testing

Products are for professional/laboratory use only

Explore Recent Scientific Contributions Using Invivoscribe’s Products

Key opinion leaders across the world have recently published papers that discuss the advantages of using highly sensitive next-generation sequencing (NGS) for Minimal Residual Disease (MRD) testing.

Illumina, invivoscribe, leukemia, lymphoma, MRD, myeloma, NGS

03Feb

Molecular